Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and niacinamide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with niacinamide in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(niacinamide)
Trials
(niacinamide)
Recent Studies (post-2010) (niacinamide)
9,15618755213,3811,0975,797

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)niacinamide (IC50)
Chain A, NAD-dependent deacetylaseThermotoga maritima1000
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)3.3
NAD-dependent protein deacetylase sirtuin-2Homo sapiens (human)2.9
NAD-dependent protein deacetylase sirtuin-3, mitochondrialHomo sapiens (human)8.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imura, Y; Maezaki, N; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and niacinamide

ArticleYear
Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21B

    Topics: Animals; Azepines; Humans; Isoquinolines; Molecular Structure; Niacinamide; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Rats; Structure-Activity Relationship; Tetrahydroisoquinolines; Triazoles

1991